FAMOTIDINE

Launch

famotidine

NDAINTRAVENOUSSOLUTION
Approved
Jul 2025
Lifecycle
Launch
Competitive Pressure
30/100
Clinical Trials
19

Mechanism of Action

Histamine H2 Receptor Antagonists

Pharmacologic Class:

Histamine-2 Receptor Antagonist

Clinical Trials (5)

NCT07171619Phase 1Recruiting

Evaluate the Effects of Famotidine or Rabeprazole on the PK of Nirogacestat

Started Sep 2025
24 enrolled
Healthy
NCT05866627Phase 1Recruiting

A Study to Assess the Effect of Famotidine on the Drug Levels of Afimetoran in Healthy Participants

Started Jul 2023
76 enrolled
Healthy Volunteers
NCT04941755Phase 1Completed

A Study to Determine the Effect of Famotidine on the Drug Levels of BMS-986256 in Healthy Participants

Started Jun 2021
22 enrolled
Healthy Participants
NCT04470778Phase 1Completed

Study to Assess the Effect of Acid-reducing Agent Famotidine on the Drug Levels of BMS-986256 in Healthy Participants

Started Jul 2020
35 enrolled
Healthy Participants
NCT04209699Phase 1Completed

A Study Comparing the Effects of Famotidine Pretreatment and of Food on the Relative Bioavailability of BMS-986165 in Healthy Volunteers

Started Dec 2019
18 enrolled
Healthy Participants